Source: Health Canada shortage reports · Updated Jul 29, 2026
Ticagrelor is in a widespread shortage in Canada. 2 of 4 reported products are affected. The latest manufacturer estimate for full recovery is Sep 25, 2026.
An antiplatelet blood thinner used to prevent blood clots after a heart attack or in heart disease.
Products affected
2 / 4
In shortage since
Apr 20, 2026
Est. full return
Sep 25, 2026
Reports on file
21
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · since Apr 20, 2026, est. end Sep 25, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-TICAGRELOR
90MG · TABLET · APOTEX INC
DIN 02482630 · since May 12, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Mar 9, 2026 · Disruption of the manufacture of the drug.
Avoided
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Nov 25, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
60MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492571 · ended Nov 28, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
60MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492571 · ended Nov 28, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Oct 31, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Sep 5, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Apr 11, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-TICAGRELOR
90MG · TABLET · APOTEX INC
DIN 02482630 · ended Jan 9, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Oct 17, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-TICAGRELOR
60MG · TABLET · APOTEX INC
DIN 02482622 · ended Jul 18, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 21 reports. All reports are on file with Health Canada.
What's happening
Ticagrelor is currently affected by 2 active shortage reports filed with Health Canada by TARO PHARMACEUTICALS INC, APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Ticagrelor is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AC).
Recent changes
Jul 29, 2026
Estimated end date pushed back : Jul 31, 2026 → Sep 25, 2026
Jul 14, 2026
Estimated end date pushed back : Jun 26, 2026 → Jul 31, 2026
Common questions
What is Ticagrelor used for?
An antiplatelet blood thinner used to prevent blood clots after a heart attack or in heart disease.
When will Ticagrelor be back in stock in Canada?
The latest manufacturer estimate is Sep 25, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Ticagrelor in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.